Upland Hills Health Healthcare Excellence in Your Community

Applications in Neurology and Psychiatry

Pinpointing epileptic foci

Of the nation's approximately 2 million patients with epilepsy, an estimated 80,000 suffer from focal (partial) epilepsy that cannot be controlled with medication. These patients may be good candidates for resection of the affected area of the brain; however, it is very difficult to accurately identify the epilepsy focus. Inserting depth electrode implants is one method of locating the foci, but it is expensive, highly invasive, and associated with high rates of mortality, morbidity and infection.

PET FDG imaging is a non-invasive and cost-effective aid in predicting the prognosis and in surgical planning for resection procedures. By revealing areas of increased and decreased glucose utilization, PET helps surgeons pinpoint the surgical site.

Diagnosing dementia

PET is being used as a tool in diagnosing a wide variety of dementias, including Senile Dementia of the Alzheimer's Type (SDAT) - the leading cause of dementia in the United States, which incapacitates 10% of people over age 65. However, more than 90% of all suspected Alzheimer's cases are classified as "indefinite diagnosis" on the basis of current tests.

PET shows a distinct pattern of decreased glucose consumption in the temporal/ parietal regions of the brain, characteristic of Alzheimer's. By providing early detection of the disease, PET can help eliminate both the uncertainty associated with indefinite diagnosis and the need for multiple expensive tests.

Evaluating movement disorders

Involuntary movement disorders such as Parkinson's Disease, Huntington's Disease, and Tourette Syndrome can be difficult to diagnose. In many cases, structural images are normal or unrevealing.

PET studies can help diagnose these diseases by revealing abnormal uptake patterns in the brain's dopamine receptors. For example, Parkinson's disease is identified by decreased uptake of 18F-DOPA in the caudate and putamen regions of the brain.

As new treatments for epilepsy, dementias, and movement disorders are developed, the need for early diagnoses provided by PET exams should likewise grow.




Epilepsy
Focal region of diminished FDG uptake in right frontal pole consistent with a hypometabolic seizure focus in the interictal state.



Alzheimer's (SDAT)
Extensive and asymmetrical metabolic abnormalities, with marked reduction in right frontal, parietal, and temporal regions; moderate hypo-metabolism in left temporal and posterior parietal regions.



Parkinson's

Patient diagnosed with Parkinson's Disease. Image exhibits diminished uptake of 18F-DOPA through the striata, especially in the putamina.

800 Compassion Way • PO Box 800 • Dodgeville, WI 53533-0800
608-930-8000 • Fax: 608-930-7250 • TDD 608-935-0008